A randomized clinical study of specifically designed isoenergetic diets, together with fecal shotgun metagenomics, showed that a select group of short-chain fatty acid (SCFA)-producing strains of the gut microbiota was promoted by dietary fibers, and correlated with improved blood-glucose regulation in type 2 diabetes mellitus (T2D). The improvement in hemoglobin A1c levels was partly via increased glucagon-like peptide-1 production. Promotion of the positive responders diminished producers of metabolically detrimental compounds such as indole and hydrogen sulfide. SCFAs act as an energy source to the colonic epithelium and are also sensed by host signaling pathways that modulate appetite and inflammation. Deficiency of gut SCFAs is associated with T2D. The gut microbiota benefits humans via SCFA production from carbohydrate fermentation. Source: http://science.sciencemag.org/
A prospective cohort study of 1,861 patients with nondialysis-dependent chronic kidney disease (CKD) in South…
A meta-analysis of 85 randomized clinical trials involving 70,543 participants found that sodium-glucose cotransporter 2…
Two randomized trials conducted in China found that endovascular therapy improved functional outcomes in patients…
A circadian subtype of depression is associated with earlier disease onset, more severe clinical features,…
A longitudinal study of 995 U.S. older adults found that frequent and unintentional daytime napping…
A multicohort genetic association study found that the ancestry-enriched CD36 Y325* variant accounted for a…
This website uses cookies.